Quipt Home Medical Corp. (TSX: QIPT)
Canada
· Delayed Price · Currency is CAD 3.760
+0.230 (6.52%)
Dec 27, 2024, 4:00 PM EST
Quipt Home Medical Income Statement
Financials in millions USD. Fiscal year is October - September.
Millions USD. Fiscal year is Oct - Sep.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Sep '24 Sep 30, 2024 | Sep '23 Sep 30, 2023 | Sep '22 Sep 30, 2022 | Sep '21 Sep 30, 2021 | Sep '20 Sep 30, 2020 | 2019 - 2015 |
| Revenue | 245.92 | 245.92 | 211.68 | 127.64 | 94.39 | 72.64 | Upgrade
|
| Revenue Growth (YoY) | 16.17% | 16.17% | 65.84% | 35.22% | 29.95% | -10.29% | Upgrade
|
| Cost of Revenue | 68.93 | 68.93 | 57.9 | 33.21 | 28.17 | 19.93 | Upgrade
|
| Gross Profit | 176.99 | 176.99 | 153.78 | 94.42 | 66.22 | 52.71 | Upgrade
|
| Selling, General & Admin | 122.54 | 122.54 | 103.22 | 65.2 | 44.66 | 38.63 | Upgrade
|
| Other Operating Expenses | - | - | - | -4.89 | - | -0.14 | Upgrade
|
| Operating Expenses | 175.58 | 175.58 | 149.73 | 88.85 | 67.39 | 53.2 | Upgrade
|
| Operating Income | 1.41 | 1.41 | 4.05 | 5.57 | -1.17 | -0.49 | Upgrade
|
| Interest Expense | -8.29 | -8.29 | -5.91 | -2.08 | -1.99 | -1.84 | Upgrade
|
| Interest & Investment Income | 0.79 | 0.79 | 0.37 | - | - | - | Upgrade
|
| Earnings From Equity Investments | -0.31 | -0.31 | -0.09 | - | - | - | Upgrade
|
| Currency Exchange Gain (Loss) | 0.04 | 0.04 | 0.11 | -0.14 | -0.17 | 0.45 | Upgrade
|
| Other Non Operating Income (Expenses) | - | - | - | - | -2.11 | -0.41 | Upgrade
|
| EBT Excluding Unusual Items | -6.36 | -6.36 | -1.48 | 3.35 | -5.45 | -2.29 | Upgrade
|
| Merger & Restructuring Charges | -0.4 | -0.4 | -1.27 | -0.8 | -0.23 | -0.09 | Upgrade
|
| Gain (Loss) on Sale of Assets | 0.11 | 0.11 | 0.08 | -0.05 | 0.09 | 0.07 | Upgrade
|
| Legal Settlements | - | - | - | - | -0.15 | - | Upgrade
|
| Other Unusual Items | - | - | -0.03 | 0.43 | -3.59 | -1.27 | Upgrade
|
| Pretax Income | -6.65 | -6.65 | -2.7 | 2.94 | -9.33 | -3.58 | Upgrade
|
| Income Tax Expense | 0.11 | 0.11 | 0.09 | -1.9 | -3.16 | 0.13 | Upgrade
|
| Earnings From Continuing Operations | -6.76 | -6.76 | -2.78 | 4.84 | -6.17 | -3.7 | Upgrade
|
| Earnings From Discontinued Operations | - | - | - | - | - | -0.87 | Upgrade
|
| Net Income | -6.76 | -6.76 | -2.78 | 4.84 | -6.17 | -4.57 | Upgrade
|
| Net Income to Common | -6.76 | -6.76 | -2.78 | 4.84 | -6.17 | -4.57 | Upgrade
|
| Shares Outstanding (Basic) | 43 | 43 | 39 | 34 | 30 | 23 | Upgrade
|
| Shares Outstanding (Diluted) | 43 | 43 | 39 | 36 | 30 | 23 | Upgrade
|
| Shares Change (YoY) | 10.09% | 10.09% | 6.35% | 19.27% | 33.96% | 9.68% | Upgrade
|
| EPS (Basic) | -0.16 | -0.16 | -0.07 | 0.14 | -0.20 | -0.20 | Upgrade
|
| EPS (Diluted) | -0.16 | -0.16 | -0.07 | 0.13 | -0.20 | -0.20 | Upgrade
|
| Free Cash Flow | 25.07 | 25.07 | 30.13 | 17.18 | 12.72 | 13.94 | Upgrade
|
| Free Cash Flow Per Share | 0.59 | 0.59 | 0.78 | 0.47 | 0.42 | 0.61 | Upgrade
|
| Gross Margin | 71.97% | 71.97% | 72.65% | 73.98% | 70.15% | 72.56% | Upgrade
|
| Operating Margin | 0.57% | 0.57% | 1.91% | 4.37% | -1.24% | -0.68% | Upgrade
|
| Profit Margin | -2.75% | -2.75% | -1.32% | 3.79% | -6.54% | -6.29% | Upgrade
|
| Free Cash Flow Margin | 10.19% | 10.19% | 14.23% | 13.46% | 13.47% | 19.19% | Upgrade
|
| EBITDA | 45.99 | 45.99 | 40.15 | 24.4 | 13.84 | 11.88 | Upgrade
|
| EBITDA Margin | 18.70% | 18.70% | 18.97% | 19.12% | 14.66% | 16.36% | Upgrade
|
| D&A For EBITDA | 44.58 | 44.58 | 36.1 | 18.83 | 15.01 | 12.38 | Upgrade
|
| EBIT | 1.41 | 1.41 | 4.05 | 5.57 | -1.17 | -0.49 | Upgrade
|
| EBIT Margin | 0.57% | 0.57% | 1.91% | 4.37% | -1.24% | -0.68% | Upgrade
|
| Revenue as Reported | 245.92 | 245.92 | 211.68 | 139.86 | 102.35 | 72.64 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.